Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Biden to send 20 mln doses of U.S.-authorized vaccines abroad for first time

Mon, 17th May 2021 18:00

(Adds China's comments, vaccine export)

By Steve Holland

WASHINGTON, May 17 (Reuters) - President Joe Biden will send
at least 20 million more COVID-19 vaccine doses abroad by the
end of June, marking the first time the United States is sharing
vaccines authorized for domestic use.

The move marks a notable pivot from the White House as the
administration seeks to use the country's vaccine supply as a
diplomatic tool with the pandemic outlook brightening at home.

Biden announced on Monday that his administration will send
doses of the Pfizer Inc/BioNTech SE, Moderna
Inc and Johnson & Johnson vaccines, on top of
60 million AstraZeneca Plc doses he had already planned
to give to other countries.

Unlike the others, AstraZeneca's shot is not yet authorized
for use in the United States.

"Just as in World War Two America was the arsenal of
democracy, in the battle against COVID-19 pandemic our nation is
going to be the arsenal of vaccines," Biden said.

The president has been under pressure to share vaccines to
help contain worsening epidemics from India to Brazil, where
health experts fear new, more contagious coronavirus variants
could undermine the effectiveness of available shots.

Biden noted that no other country will send more vaccines
abroad than the United States. So far, the United Stages has
sent a few million AstraZeneca doses to Canada and Mexico.

"We want to lead the world with our values with this
demonstration of our innovation, ingenuity, and the fundamental
decency of American people," Biden said.

China, which has exported hundreds of millions of doses
mainly to developing countries and pledged to donate at least
nearly 4 million doses, said it welcomed the U.S. move but it
would not use vaccines as a tool in diplomatic relations.

"We welcome if the U.S. can implement its commitment to
vaccine assistance at an early date and provide tangible help to
developing countries in their fight against the epidemic," Zhao
Lijian, a spokesman at China's foreign ministry, said.

"Unlike the United States, China will not use vaccine
influence to lead the world and will not chant empty slogans
without action," he said at a regular briefing on Tuesday.

The White House has not provided any details about what
countries will receive the shots. Biden said that Jeff Zients,
who heads the U.S. vaccine efforts, will now also lead the
global vaccine push.

The United States has administered more than 272 million
COVID-19 vaccine doses and distributed more than 340 million,
according to federal data updated on Monday morning.

With more and more Americans vaccinated, U.S. deaths from
COVID-19 last week fell to their lowest in nearly 14 months,
while the number of new cases declined for a fifth consecutive
week, according to a Reuters analysis of state and county data.

Biden warned that those who do not get vaccinated "will end
up paying the price" as he lamented that "we're still losing too
many Americans" despite the significant progress.

(Reporting By Steve Holland, Carl O'Donnell and Jarrett
Renshaw; Additional reporting by Beijing Newsroom; Writing by
Jarrett Renshaw; Editing by Trevor Hunnicutt, Bill Berkrot and
Andrew Heavens)

More News
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.